Login to Your Account

Pharma: Other news to note

Wednesday, December 11, 2013
Baxter International Inc., of Deerfield, Ill., said it submitted a biologics license application for the approval of OBI-1, a recombinant antihemophilic porcine sequence Factor VIII, in patients with acquired hemophilia A.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription